STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIRB) and Cancer Research Technology (CRT), Cancer Research UK’s commercialization and development arm, today jointly announce a partnership to develop a new class of drugs that has shown promise for treating a range of different cancers, including pancreatic cancer.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
